Probiotec Monthly Outlook (April 2026) | Price, Target Price & Growth

Probiotec

ASX:PBP

$ 3,03

$0,00 (0,00%)

3,03 $

$0,00 (0,00%)

End-of-day quote: 05/31/2024

Probiotec Stock Value

Currently, analysts rate Probiotec as sf_Data Unavailable.

Probiotec Company Info

EPS Growth 5Y

21,67%

Market Cap

$0,24 B

Long-Term Debt

$0,05 B

Quarterly earnings

N/A

Dividend

$0,00

Dividend Yield

0,00%

Founded

1996

Industry

Health Care

Country

Australia

Website

Probiotec

ISIN Number

AU000000PBP7

Website

http://www.probiotec.com.au

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Probiotec’s Price Target has risen from $3,00 to $3,00 - a 0,00% increase. One analysts predict that Probiotec’s share price will fall in the coming year, reaching $0,00. This would represent a decrease of -100,00%.

Top growth stocks in the health care sector (5Y.)

What does Probiotec do?

Probiotec Limited operates primarily in the pharmaceutical and nutritional product sectors. Business Segments The company operates through Pharmaceutical Manufacturing, Nutritional Products, Contract Manufacturing Services, and Research and Development. Pharmaceutical Manufacturing The Pharmaceutical Manufacturing segment involves the production of various pharmaceutical products, including prescription medications and over-the-counter drugs. This segment adheres to stringent quality standar...

Probiotec Limited operates primarily in the pharmaceutical and nutritional product sectors.

Business Segments

The company operates through Pharmaceutical Manufacturing, Nutritional Products, Contract Manufacturing Services, and Research and Development.

Pharmaceutical Manufacturing

The Pharmaceutical Manufacturing segment involves the production of various pharmaceutical products, including prescription medications and over-the-counter drugs. This segment adheres to stringent quality standards, ensuring compliance with Good Manufacturing Practices (GMP) to deliver affordable healthcare solutions.

Nutritional Products

The Nutritional Products segment engages in the development and production of nutritional supplements, such as probiotics, vitamins, and specialty blends. This division focuses on formulating products that meet consumer health needs while ensuring safety through extensive research.

Contract Manufacturing Services

The Contract Manufacturing Services segment involves providing tailored solutions for clients, including private label services that allow brands to utilize Its facilities and expertise.

Research and Development

The Research and Development segment engages in innovative projects aimed at expanding product offerings and maintaining competitiveness in the evolving pharmaceutical landscape.

Business Strategy

The company’s strategy emphasizes continuous improvement and expansion through investments in research and development, aiming to innovate existing product lines and develop new offerings. It is also actively seeking growth prospects through strategic acquisitions, enhancing its market position and operational capabilities.

Products and Services

The company offers a comprehensive range of products, including prescription pharmaceuticals across various therapeutic categories, ensuring effective treatment solutions for healthcare professionals and patients. The nutritional supplements line features dietary aids, vitamins, minerals, and probiotics, all formulated based on the latest scientific research.

The company provides contract manufacturing and custom formulation solutions, allowing clients to leverage its expertise and facilities. The packaging services focus on innovative solutions that maintain brand integrity and comply with safety regulations, using eco-friendly materials where possible.

Geographical Markets Served

The company serves a broad geographical market, primarily in Australia, and extends its services internationally. It also caters to local healthcare providers, pharmacies, and health-conscious consumers while enhancing its global footprint.

Seasonality

The company experiences seasonality in its operations, particularly with nutritional supplements, which often see increased demand during winter months when consumers focus on immune health. Despite this, the company's diverse product range helps mitigate risks associated with fluctuating demand.

Customers

The company serves a diverse clientele, including healthcare professionals, pharmacies, hospitals, and wholesalers. Its products cater to health-conscious consumers and businesses seeking high-quality nutritional and pharmaceutical solutions.

Sales and Marketing Channels

The company employs various sales and marketing strategies, including direct selling through partnerships with healthcare providers, e-commerce platforms, and distribution agreements with wholesalers and retail outlets. It also leverages digital marketing channels to enhance brand visibility and engage consumers effectively.

History

Probiotec Limited was incorporated in 1996.

New support ticket

Explore

Probiotec Stock Value

Probiotec Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Probiotec do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Probiotec Stock Value

Probiotec Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Probiotec do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.